Mohammad Ismail
Higher Degree by Research Candidate
South Australian Immunogenomics Cancer Institute
Faculty of Health and Medical Sciences
I'm a PhD candidate in the Prostate Cancer Research Group at SAHMRI, under the supervision of Dr. Zeyad Nassar and led by Professor Lisa Butler. My research centers on investigating the genetic landscape of prostate cancer, specifically targeting key metabolic pathways in prostate cancer. I'm deeply passionate about this endeavor and excited to contribute to our team's mission.
-
Appointments
Date Position Institution name 2019 - 2022 Research Assisstant Cell Therapy Center, Amman 2017 - 2018 Medical Laboratory Technician AL-Istiashari Hospita; -
Language Competencies
Language Competency Arabic Can read, write, speak and understand spoken English Can read, write, speak and understand spoken -
Education
Date Institution name Country Title 2018 - 2021 The University of Jordan Jordan Masters Degree 2013 - 2017 Hashemite University Jordan Bachelors Drgree -
Research Interests
-
Journals
Year Citation 2023 Alrabayah, M., Massad, I. M., Imraish, A., Jarrar, Y., Massad, F., Guzu, H., . . . Zihlif, M. (2023). Effects of <i>CYP2B6</i> Genetic Variants on the Propofol Dose and Response among Jordanian Arabic Patients Undergoing General Anesthesia. CURRENT DRUG METABOLISM, 23(14), 1156-1161.
2023 El-Sadoni, M., Al Shboul, S., Alhesa, A., Shahin, N. A., Alsharaiah, E., Ismail, M. A., . . . Saleh, T. (2023). A three-marker signature identifies senescence in human breast cancer exposed to neoadjuvant chemotherapy. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 91(4), 345-360.
Europe PMC12023 Asad, M. M., Abdelhafez, R. S., Barham, R., Abdaljaleel, M., Alkurdi, B., Al-Hadidi, S., . . . Ababneh, N. A. (2023). Three-dimensional cultures of gingival fibroblasts on fibrin-based scaffolds for gingival augmentation: A proof-of-concept study. ARCHIVES OF ORAL BIOLOGY, 154, 8 pages.
2023 Abu-Humaidan, A., Ismail, M. A., Barham, R., Ahmad, F. M., Ababneh, N. A., & Saleh, T. (2023). Therapy induced senescence in cancer cell lines affects complement activation and complement regulatory proteins expression. IMMUNOBIOLOGY, 228(5), 93.
2023 Al Shboul, S., El-Sadoni, M., Alhesa, A., Abu Shahin, N., Abuquteish, D., Abu Al Karsaneh, O., . . . Saleh, T. (2023). NOXA expression is downregulated in human breast cancer undergoing incomplete pathological response and senescence after neoadjuvant chemotherapy. Scientific Reports, 13(1), 1-12.
2023 COVID-19 Host Genetics Initiative. (2023). A second update on mapping the human genetic architecture of COVID-19.. Nature, 621(7977), E7-E26.
Europe PMC12022 Ababneh, N. A., Barham, R., Al-Kurdi, B., Ali, D., Al Hadidi, S., Ismail, M. A., . . . Awidi, A. (2022). Generation of a human induced pluripotent stem cell (iPSC) line (JUCTCi019-A) from a patient with Charcot-Marie-Tooth disease type 2A2 (CMT2A2) due to a heterozygous missense substitution c.2119C > T (p. Arg707Trp) in MFN2 gene. STEM CELL RESEARCH, 62, 5 pages.
WoS1 Europe PMC22021 Sweidan, N., Esawi, E., Ismail, M., & Alshaer, W. (2021). Anticancer Cardenolides from the aerial parts of Calortopis procera. Zeitschrift fur Naturforschung - Section C Journal of Biosciences, 76(5), 243-250.
Scopus2 WoS1 Europe PMC12020 Odeh, F., Nsairat, H., Alshaer, W., Ismail, M. A., Esawi, E., Qaqish, B., . . . Ismail, S. I. (2020). Aptamers Chemistry: Chemical Modifications and Conjugation Strategies. MOLECULES, 25(1), 51 pages.
WoS154 Europe PMC75 -
Book Chapters
Year Citation 2022 Nsairat, H., Alshaer, W., Mahmoud, I. S., Ismail, M. A., Esawi, E., Alsotari, S., & Ismail, S. I. (2022). Aptamers in Theranostic Bionanomaterials. In Bionanotechnology: Next-Generation Therapeutic Tools (pp. 130-158). BENTHAM SCIENCE PUBLISHERS.
Connect With Me
External Profiles
